Nucleavir ointment 5g №1

Name:
Nucleavir ointment for nar. in tubes 5g in unitary enterprise No. 1
Description:
Ointment of white or white color with a grayish-yellowish tinge. The main active ingredient Cyclocytidine monophosphate Release form Ointment Pharmacological action The active principle of the drug is cyclocytidine monophosphate (c-CMP) – a synthetic analogue of a purine nucleoside that has activity against human herpes viruses, including Herpes simplex virus types 1 and 2, Varicella Zoster virus. The drug is effective in case of resistance to acyclovir and phosphonoacetic acid. It has a direct virus inhibitory effect, provides a complete blockade of the virus in the pathological focus. Reduces itching, swelling, hyperemia of the skin and mucous membranes. Prevents the formation of new elements of the rash, reduces the likelihood of skin dissemination and visceral complications, accelerates the formation of crusts. Helps reduce pain when used in the acute phase of herpes zoster. Indications for use The drug is used for infections of the skin and mucous membranes caused by the herpes simplex virus, including primary and recurrent genital herpes; in primary and recurrent infections caused by the herpes zoster virus in patients without impaired immunity. The drug is especially indicated for use in patients with chronic relapsing course of herpesvirus infection, with resistance to standard antiherpetic therapy. Method of application and doses The drug is applied to the lesion five times a day with an interval of 4 hours. The duration of the course of treatment in patients with lichen simplex (Herpes simplex) and genital herpes (Herpes genitalis) is at least 7-14 days, in patients with herpes zoster (Herpes zoster) – 14-21 days. Treatment with the drug must be continued for 3 days after the disappearance of signs of the disease. The drug can not be used to treat ophthalmic herpes and other eye diseases. Use during pregnancy and lactation Use during pregnancy and lactation is contraindicated. Influence on the ability to drive vehicles and other potentially dangerous mechanisms Does not affect. Precautions It is recommended to start treatment at the very first signs of the disease. Interaction with other drugs It is possible to simultaneously prescribe the drug with zinc ointment, a solution of brilliant green 2% alcohol. There were no undesirable side reactions with simultaneous use with benzylpenicillin (in the form of sodium and novocaine salts), clarithromycin, metronidazole, metamizole, acetylsalicylic acid, aloe, vitamins B1, B6, C. Contraindications Increased individual sensitivity to the drug. Due to the lack of relevant human trials, there is a potential risk of adverse effects during pregnancy and lactation (it is necessary to stop breastfeeding for the period of treatment). Composition Per tube: active substance: cyclocytidine monophosphate monohydrate – 250 mg; excipients: macrogol 400, macrogol 1500. Overdose Overdose phenomena when using the drug are not described. Side effects As a rule, no adverse effects are observed when using the drug. In rare cases, allergic reactions (skin rash, itching) are possible, disappearing after drug withdrawal. In the event of the above adverse reactions, as well as adverse reactions not listed in this leaflet for the use of the drug, you should consult a doctor. Storage conditionsStore at a temperature not exceeding 25°C. Keep out of the reach of children. Buy Nucleavir ointment 5g №1 Price for Nucleavir ointment 5g №1Instruction for use for Nucleavir ointment 5g №1